# SAM #75A50126C00011

HHS $48.9 Million Award to Develop the OXOS X3 Portable X-Ray System

**Buyer:** ASPR BARDA
**Posted:** September 29, 2026
**Respond By:** September 25, 2026
**Identifier:** 75A50126C00011
**NAICS:** 541714, 334510, 334517

HHS has awarded OXOS Medical, Inc. a $48.9 million contract to advance development of its portable X-ray imaging system for trauma and mass-casualty response.
- Award and buyer
  - Awardee and OEM: OXOS Medical, Inc.
  - Agency: U.S. Department of Health and Human Services (HHS); the initial notice identifies BARDA as the program office.
  - Contracting office: Constitution Center, Contracting Office.
  - Award date: September 25, 2026.
  - Award value: $48.9 million.
- What is being developed
  - The OXOS X3 is an ultraportable system for general radiography and fluoroscopy, intended to provide diagnostic imaging where patients are being treated, including emergency and field settings.
  - Stated specifications: under 25 pounds and output up to 100 kV / 15 mA.
  - The system is intended for trauma response and mass-casualty incidents and is described as a threat-agnostic medical countermeasure.
  - The development effort includes pursuing FDA clearance; the notice does not state that clearance has already been obtained.
- Schedule and quantities
  - The contract was awarded on September 25, 2026; no end date or contract duration is provided.
  - No unit quantity or separate product or service line-item quantities are specified.

### Description

<p>Transform trauma response by bringing hospital-grade imaging directly to the point of need by developing and receiving FDA clearance of the OXOS X3, an ultra-portable, high-output general radiography and fluoroscopy system engineered to function as a threatagnostic medical countermeasure (MCM). Designed to weigh under 25 pounds and deliver up to 100 kV / 15 mA at the point of need, X3 augments the transport-to-imaging bottleneck that currently degrades survival in mass casualty incidents (MCIs) involving nuclear detonation, conventional blast, or large-scale trauma surge events. By bringing hospital-grade diagnostic capability directly to the casualty, whether in a high-volume Emergency Department, a temporary field hospital, or a triage site, X3 restores the diagnostic foundation of the ATLS primary survey at every step where current portable assets fail.</p>

[View original listing](https://sam.gov/opp/10b23f5dd399446881c691d10e225e80/view)